Looking forward
to seeing you
at ILCA 2019
September  21-22
Marriott Downtown Magnificent Mile
Chicago, IL

Learn more

a new level of control

LC Bead LUMI™ the first radiopaque embolic bead


LC Bead LUMI Revolutionizing the Treatment of HCC


Available in smaller 40-90µm size
to support distal tumor penetration


CBT ≤ 90 mins post LUMI-embolization

This case was impressive because of the clear visualization of the tumor and the embolized vessels on the post-embolization non-contrast CBCT, in addition to the complete response of the related lesions.

CBT 10 mins post LUMI-embolization

After 4 weeks of follow-up, a complete response on mRECIST was demonstrated with a decrease in tumor size to 0.9 mm.

CT post LUMI-embolization

The radiopaque property of LC Bead LUMI™ allows for accurate needle placement and full lesion ablation. If the lesion cannot be seen on non-contrast CT, there is a possibility that the lesion may not be fully ablated.

LC Bead Lumi KOL

The content of these cases is designed to highlight some of the benefits of LC Bead LUMI™ embolization therapy treatment, based on initial cases performed by various Interventional Radiologists. 
Examples are presented of LC Bead LUMI™ in the treatment of hepatocellular carcinoma showing the distribution of LC Bead LUMI™ in intra-tumoral and tumor feeding vessels on CBCT and non-enhanced computed tomography scans. These illustrative cases demonstrate the benefits of LC Bead LUMI™ in offering the IR greater vision, precision and assurance both during and after the procedure.